Nov 2022

FAIR Data Foundation: An Enabler for AI Drug Discovery

Biomedical data used in AI-enabled drug discovery should adhere to the FAIR Data Principles — Findability, Accessibility, Interoperability and Reusability. This blog explains why this is, how one can make data FAIR and challenges that remain.
Sep 2022

Building the data foundations to accelerate drug discovery

Mark Davies, BenevolentAI’s SVP Informatics and Data, discusses innovations that enable BenevolentAI to leverage biomedical data in drug discovery.
Jul 2022

Fueling continuous innovation at BenevolentAI

BenevolentAI’s CTO, Daniel Neil, discusses the approaches we use to fuel continuous innovation in order to unlock new opportunities and future growth.
May 2022

FDA converts emergency approval of baricitinib — first identified as a COVID treatment by BenevolentAI — to a full approval

The FDA has converted its emergency approval of baricitinib to a full approval, underscoring the strength of BenevolentAI’s AI-derived hypothesis.